3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
14
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma, Follicular
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma
5
Sarcoma, Ewing
3
Rhabdomyosarcoma, Embryonal
3
Rhabdomyosarcoma
3
Neoplasms
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Leukemia, Biphenotypic, Acute
3
Down Syndrome
3
Rhabdomyosarcoma, Alveolar
2
Medulloblastoma
2
Lymphoproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell, Marginal Zone
2
Hepatoblastoma
2
Wilms Tumor
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Sarcoma
1
Rhabdoid Tumor
1
Pleuropulmonary blastoma
1
PRETEXT I Hepatoblastoma
1
Osteosarcoma
1
Neuroblastoma
1
Interventions
Cyclophosphamide
10
Nivolumab
7
pembrolizumab
6
fludarabine phosphate
6
fludarabine
5
Mycophenolic Acid
5
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
Doxorubicin
4
Dacarbazine
4
Cyclosporine
4
Brentuximab Vedotin
4
Whole-Body Irradiation
3
Vinblastine
3
Radiotherapy
3
Filgrastim
3
Etoposide
3
Busulfan
3
Tacrolimus
2
Sirolimus
2
Radiation
2
Peripheral Blood Stem Cell Transplantation
2
Melphalan
2
Granulocyte Colony-Stimulating Factor
2
Clofarabine
2
Carmustine
2
tocilizumab
1
thymoglobulin
1
tafasitamab
1
polatuzumab vedotin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
Vincristine
×
30 days
×
Clear all
No trials found.